CAH - Your Daily Pharma Scoop: Wright Receives PMA Allergan And Corbus Report Positive
Analysis Focus: WMGI
Wright Medical Group N.V. (WMGI) stock prices climbed +4.46% to $25.78 on the news of its receipt of FDA premarket approval (‘PMA) for Augment. Augment, an injectable bone graft, is a combination product containing human platelet derived growth factor (rhPDGF-BB) and a blend of Type I collagen and Beta tricalcium phosphate. The combination is used as a safe and effective alternative to autograft for use in hindfoot and ankle fusion in an easy to use flowable formulation.
Augment Injectable and Augment Bone Graft are used for the same indication. This